|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/14/24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/14/23 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -1.06% | -15.56% | -29.33% | 24TCr | ||
| -0.96% | -0.28% | -44.96% | -56.47% | 4.12TCr | ||
| -2.49% | -0.77% | -43.64% | -54.58% | 2.16TCr | ||
| -2.72% | -1.57% | -46.40% | -67.93% | 1.69TCr | ||
| -0.95% | -5.71% | +5.21% | +30.04% | 1.05TCr | ||
| -1.64% | -0.70% | -47.51% | -71.85% | 878.23Cr | ||
| +0.31% | +0.77% | +0.70% | -51.57% | 798.09Cr | ||
| -3.93% | -2.49% | -45.89% | -66.64% | 685.13Cr | ||
| -2.86% | -1.73% | -30.88% | -53.04% | 565.03Cr | ||
| Average | -1.74% | -4.08% | -29.88% | -46.82% | 4TCr | |
| Weighted average by Cap. | -0.87% | -3.53% | -22.69% | -36.65% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















